Soluble T cell immunoglobulin and mucin-domain containing protein 3 in children hospitalized with pneumonia in resource-limited settings

被引:1
|
作者
Ahmed, Usman [1 ]
Soo, Jeremy [1 ]
Conroy, Andrea L. [2 ]
Namasopo, Sophie [3 ]
Opoka, Robert O. [4 ,5 ]
Bhargava, Ravi [6 ]
Hawkes, Michael T. [1 ,7 ,8 ,9 ,10 ]
机构
[1] Univ Alberta, Dept Pediat, 3-588D Edmonton Clin Hlth Acad,11405 87 Ave NW, Edmonton, AB T6G 1C9, Canada
[2] Indiana Univ Sch Med, Ryan White Ctr Pediat Infect Dis & Global Hlth, Indianapolis, IN USA
[3] Kabale Dist Hosp, Dept Paediat, Kabale, Uganda
[4] Mulago Hosp, Dept Paediat & Child Hlth, Kampala, Uganda
[5] Makerere Univ, Kampala, Uganda
[6] Univ Alberta, Dept Radiol & Diagnost Imaging, Edmonton, AB, Canada
[7] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada
[8] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada
[9] Stollery Sci Lab, Edmonton, AB, Canada
[10] Women & Childrens Hlth Res Inst, Edmonton, AB, Canada
关键词
sTIM-3; Pediatric pneumonia; Respiratory Index of Severity in Children; Biomarker; Africa; Prospective cohort study; RESPIRATORY RATE; DIAGNOSIS; DISEASE; HEART;
D O I
10.1016/j.cyto.2022.155794
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Y In a prospective cohort study of 77 children with severe pneumonia from two hospitals in Uganda, we assessed soluble T cell immunoglobulin and mucin-domain containing protein 3 (sTIM-3) levels at hospital admission and their association with pneumonia severity and subsequent mortality. sTIM-3 levels were positively correlated with the Respiratory Index of Severity in Children (RISC) (rho = 0.35, p = 0.0017), sTIM-3 levels were higher in children who required transfer to a tertiary hospital (p = 0.014) and in fatal cases (p = 0.011). In summary, sTIM-3 is associated with disease severity and predictive of mortality in childhood pneumonia in resource-limited settings.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] T-cell immunoglobulin and mucin-domain containing-3 in malignant cancers
    Xu, Yun
    Jiang, Xiping
    Huang, Yaqing
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 (03) : 613 - 619
  • [2] Structure and Functions of T-cell Immunoglobulin-domain and Mucin-domain Protein 3 in Cancer
    Lu, Xinjie
    CURRENT MEDICINAL CHEMISTRY, 2022, 29 (11) : 1851 - 1865
  • [3] T cell immunoglobulin and mucin-domain containing-3 in non-small cell lung cancer
    Jia, Keyi
    He, Yayi
    Dziadziuszko, Rafal
    Zhao, Sha
    Zhang, Xiaoshen
    Deng, Juan
    Wang, Hao
    Hirsch, Fred R.
    Zhou, Caicun
    Yu, Hui
    Zhang, Liping
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (06) : 895 - +
  • [4] The prospect of targeting T cell immunoglobulin and mucin-domain containing-3 in renal cell carcinoma immunotherapy
    Mohsenzadegan, Monireh
    Nowroozi, Mohammad Reza
    Fotovvat, Amirreza
    Bavandpour Baghshahi, Parizad
    Bokaie, Saied
    Inanloo, Seyed Hassan
    Sharifi, Laleh
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2022, 96 (03)
  • [5] Serum Levels of T Cell Immunoglobulin and Mucin-Domain Containing Molecule 3 in Patients with Systemic Lupus Erythematosus
    Asano, Tomoyuki
    Matsuoka, Naoki
    Fujita, Yuya
    Matsumoto, Haruki
    Temmoku, Jumpei
    Yashiro-Furuya, Makiko
    Sato, Shuzo
    Suzuki, Eiji
    Kobayashi, Hiroko
    Watanabe, Hiroshi
    Migita, Kiyoshi
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 9
  • [6] T-cell immunoglobulin and mucin-domain containing protein (TIM) structural dynamics revealed by molecular dynamics simulations
    Rosenfeld, Mia A.
    Kearns, Fiona L.
    Chongsaritsinsuk, Joan
    Steigmeyer, Alexandra
    Mahoney, Kiera E.
    Lucas, Taryn
    Ince, Deniz
    Battison, Alexandria
    Hollenhorst, Marie A.
    Shon, D. Judy
    Attah, Victor
    Kwon, Catherine
    Bertozzi, Carolyn R.
    Malaker, Stacy A.
    Amaro, Rommie E.
    BIOPHYSICAL JOURNAL, 2023, 122 (03) : 204A - 204A
  • [7] T-cell immunoglobulin and mucin-domain containing-3 (TIM-3): Solving a key puzzle in autoimmune diseases
    Chen, Huihui
    Zha, Jie
    Tang, Runyan
    Chen, Guochun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 121
  • [8] The Potential of T Cell Immunoglobulin and Mucin-Domain Containing-3 (Tim-3) in Designing Novel Immunotherapy for Bladder Cancer
    Mohsenzadegan, Monireh
    Bavandpour, Parizad
    Nowroozi, Mohammad Reza
    Amini, Erfan
    Kourosh-Arami, Masoumeh
    Momeni, Seyed Ali
    Bokaie, Saied
    Sharifi, Laleh
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2021, 21 (12) : 2131 - 2146
  • [9] Upregulation of T-cell Immunoglobulin and Mucin-Domain Containing-3 (Tim-3) in Monocytes/Macrophages Associates with Gastric Cancer Progression
    Wang, Zhenxin
    Yin, Ni
    Zhang, Zixiang
    Zhang, Yi
    Zhang, Guangbo
    Chen, Weichang
    IMMUNOLOGICAL INVESTIGATIONS, 2017, 46 (02) : 134 - 148
  • [10] Prognostic value of T cell immunoglobulin and mucin-domain containing-3 expression in upper gastrointestinal tract tumors: A meta-analysis
    Yan, Jing-Jing
    Liu, Bing-Bing
    Yang, Yan
    Liu, Meng-Ru
    Wang, Han
    Deng, Zhen-Quan
    Zhang, Zhi-Wei
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 15 (12)